Sector ratings Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:36 2026-01-21 EST			5-day change	1st Jan Change
114.34 ^CHF	+0.07%		-1.48%	+4.32%

09:49am	Zura Bio Appoints Sandeep Kulkarni as CEO	MT
08:42am	NOVARTIS AG : Gets a Sell rating from Goldman Sachs	ZD

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
NOVARTIS AG	278B		AAA
ELI LILLY AND COMPANY	932B		A
JOHNSON & JOHNSON	526B		BBB
ABBVIE INC.	378B		AA
ROCHE HOLDING AG	374B		AA
ASTRAZENECA PLC	282B		A
NOVO NORDISK A/S	272B		A
MERCK & CO., INC.	272B		A
AMGEN INC.	178B		A
GILEAD SCIENCES, INC.	154B		AAA
PFIZER INC.	145B		BBB
VERTEX PHARMACEUTICALS INCORPORATED	112B		AA
SANOFI	111B		A
BRISTOL-MYERS SQUIBB COMPANY	110B		A
GSK PLC	96.99B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	85.9B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	57.77B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	50.63B		AA
BAYER AG	49.47B		AA
Average	226.43B		AA
Weighted average by Cap.			AA